Corey N. Fishman
2018
In 2018, Corey N. Fishman earned a total compensation of $1.8M as President and Chief Executive Officer at Iterum Therapeutics plc, a 133% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $305,910 |
|---|---|
| Option Awards | $953,529 |
| Salary | $494,946 |
| Other | $2,622 |
| Total | $1,757,007 |
Fishman received $953.5K in option awards, accounting for 54% of the total pay in 2018.
Fishman also received $305.9K in non-equity incentive plan, $494.9K in salary and $2.6K in other compensation.
Rankings
In 2018, Corey N. Fishman's compensation ranked 6,372nd out of 14,244 executives tracked by ExecPay. In other words, Fishman earned more than 55.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,372 out of 14,244 | 55th |
Division Manufacturing | 2,435 out of 5,765 | 58th |
Major group Chemicals And Allied Products | 906 out of 2,128 | 57th |
Industry group Drugs | 761 out of 1,817 | 58th |
Industry Pharmaceutical Preparations | 590 out of 1,391 | 58th |
Source: SEC filing on April 25, 2019.
Fishman's colleagues
We found two more compensation records of executives who worked with Corey N. Fishman at Iterum Therapeutics plc in 2018.